Zahlte zuletzt am 27.08.2020 eine Dividende von 10 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Pfizer Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Pfizer Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Pfizer Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Pfizer Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
35 News & Informationen zur Pfizer Limited Aktie
It's Jackson Hole Day And Futures Are Going Nowhere
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Buy USDINR; target of: 74.48 : ICICI Direct
US dollar declined 0.11% amid rise in risk appetite in global markets.
Sensex hits fresh all-time high: Key factors driving the market
An important development in the banking space is HDFC Bank bouncing back smartly. HDFC bank has the potential to regain its leadership position. Meanwhile, smart money (FIIs) continue to be on the sell mode. DIIs and retail investors continue to be exuberant about the rally regardless of valuations, said an analyst.
Sensex, Nifty end at fresh lifetime highs; Bajaj Finserv rises 8%
Read more about Sensex, Nifty end at fresh lifetime highs; Bajaj Finserv rises 8% on Business Standard. Elsewhere in Asia, bourses in Shanghai, Hong Kong, Tokyo and Seoul ended with strong gains
Sensex, Nifty end at fresh lifetime highs
BSE Sensex ended 403.19 points or 0.73% higher at its lifetime peak of 55,958.98; NSE Nifty surged 128.15 points or 0.78% to its all-time closing high of 16,624.60
Bulls push Sensex, Nifty higher for second day straight; here’s what experts make of today’s trade
S&P BSE Sensex ended the day 403 points or 0.73% higher at 55,958 points while the NSE Nifty zoomed 0.78% to close at 16,624.
A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings
Pre-open movers
U.S. stock futures traded higher in early pre-market trade after the Dow Jones and Nasdaq surged more than 200 points each in the previous …
Indian shares gain on metals boost, U.S. vaccine approval
India's benchmark stock indexes rose on Tuesday, driven by metals and technology stocks, with investor sentiment buoyed by a full U.S. approval for a COVID-19 vaccine…. | August 24, 2021
ETMarkets Morning Podcast: Is this the beginning of the end of broader market rally?
Tune in as we tell you what's happening in the market, what's making news this morning, and look at some of the buzzing stocks.
Nifty Seen Opening Above 16,500; Maruti Suzuki, Eicher Motors In Focus
Foreign institutional investors sold shares worth Rs 1,363.36 crore while domestic institutional investors bought shares worth Rs 1,452.51 on Monday.
Booster dose: Cadila share doubles in 18 months
Since vaccine development to EUA , Zydus Cadila stock surges 111%
Share Market Live: SGX Nifty Hints At Gains; Aptus Value, Chemplast Sanmar To List Today
Catch all live updates on share prices, index moves, corporate announcements and more from Indian stock markets today.
Stocks vs ETFs: 58% of all new investments in 2021 on Globalise were made in ETFs: CEO Viraj Nanda
While investor interest has widened beyond the FAANG stocks, they continue to rank amongst the most popular stocks on Globalise.
Windlas Biotech IPO share allotment likely to be finalised on August 11
Windlas Biotech shares were available for trading at a premium of Rs 65 or 14.1 percent in the grey market, compared to expected final issue price of Rs 460, the IPO Watch data showed. The trading price comes to Rs 525 per share.
Cipla CFO says drug maker to outperform domestic market in FY22, Moderna vaccine import may take time
In an interview to Moneycontrol, Cipla's Global Chief Financial Officer Kedar Upadhye expressed confidence that the company will outperform domestic formulation market and clock EBITDA margins of 22.5–23 percent for FY22.
Peptones: over 100 years of life-saving innovation
After a century, peptones continue to play a vital role in biopharmaceutical innovation
Ahead of Market: 12 things that will decide stock action on Monday
Gaurav Ratnaparkhi of Sharekhan said a brief pause in market rally is a good sign as it would allow the overbought hourly momentum indicators to cool off and prepare for the next cycle on the upside.
Windlas Biotech IPO: 10 key things to know before the issue opens
Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations CDMOs in terms of revenue, with focus on the chronic therapeutic category.
Futures Rise, Europe Hits Record Supported By Fed, China, Earnings
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Trade setup for Wednesday: Top 15 things to know before Opening Bell
The Nifty50 is approaching its four to six weeks multiple support zone of 15,700-15,600 levels, which remains a crucial level to watch for, said Rajesh Palviya of Axis Securities.
Indices rebound as stimulus, earnings help offset coronavirus fears
Read more about Indices rebound as stimulus, earnings help offset coronavirus fears on Business Standard. Analysts said though markets are concerned about the delta variant the availability of more vaccines is reassuring
Ahead of Market: 10 things that will decide stock action on Wednesday
Independent analyst Manish Shah said the 15,900-15,950 zone has been tested three times. “The general rule is that the price should go through the fourth time. Odds of an upside breakout are higher,” he said.
Growth, valuation worries may keep lid on optimism in Zomato IPO week
“The biggest risk to GREED & fears pro-cyclical view has always been that the vaccines cease to be effective against the new variants, such as the Delta variant, concerns about which are growing,” Jefferies Global Equity Strategist Christopher Woods said.
Futures Start Second Half Hovering At All Time Highs As Oil Jumps
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Zydus Cadila aims to produce 1 crore Covid-19 vaccine doses per month
'Our target is to produce 10 crore vaccine doses in a year,' says Sharvil Patel, MD, Zydus Cadila. Patel said the vaccine when approved will help not only adults but also adolescents in the 12 to 18 years age group
Supreme Court sets aside Indoco’s request to lift injunction on launch of generic apixaban
Apex court dismisses Indoco’s petition to lift the stay on producing copycat versions of Bristol Myers Squibb’s bestselling anticoagulant medication
Cipla hits 52-week high as company seeks DCGI nod to import Moderna's COVID jab
The firm submitted its application to the drugs regulator on June 28, CNBC TV-18 has reported.
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street
Pre-open movers
U.S. stock futures traded higher in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session.
The …
Can the Pfizer and Moderna Vaccines Beat the New Coronavirus Strains?
Two mRNA COVID vaccines aced clinical trials. Now new virus variants are putting them to the test.
If You Invested $5,000 in Pfizer a Year Ago, This Is How Much You Would Have Today
The world's top coronavirus vaccine drugmaker has been underperforming. I think 2021 will change that.
Evening Update: Canada facing ‘unfortunate’ delay in Pfizer vaccine deliveries
Also: Ottawa targets artists for possible repayment of emergency benefits related to pandemic
Pfizer vaccines shipments temporarily cut in half as Canada projects rapid growth in pandemic
Retooling to expand manufacturing facility will mean reduced shipments over four-week period
Mount Sinai is booking 100 patients a minute to receive the COVID-19 vaccine using Zocdoc's new scheduling service
New York's Mount Sinai Health System is booking 100 patients a minute to receive the Covid-19 vaccine using a new scheduling service through Zocdoc.
Should You Really Invest in Pfizer Stock in 2021?
Why chasing trends may not always be a good idea.
Biden to speed release of coronavirus vaccines
The American Hospital Association estimates that the nation would need to vaccinate 1.8 million people a day, every day, from Jan. 1 to May 31, to reach the goal of having widespread immunity by the summer.